ARIAD PHARMACEUTICALS INC Patent Applications Rejected
29 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-07-28: Application 18361430; Invention AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS; Applicant Ariad Pharmaceuticals, Inc.; Status Abandoned -- Failure to Pay Issue Fee.
- 2023-02-27: Application 18175272; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-08-15: Application 17819791; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2022-02-07: Application 17650234; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | 18361430 | AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS | Ariad Pharmaceuticals, Inc. | Abandoned -- Failure to Pay Issue Fee | US20240208960A1 | Nicholas E. Bencivenga David C. Dalgarno Joseph M. Gozgit Wei-Sheng Huang Anna Kohlmann Feng Li Jiwei Qi William C. Shakespeare Ranny M. Thomas Yihan Wang Xiaotian Zhu | United States United States United States United States United States United States United States United States United States United States United States | SHAMEEM, GOLAM M |
| 2023-02-27 | 18175272 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20240083902A1 | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | WARD, PAUL V |
| 2022-08-15 | 17819791 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | ||
| 2022-02-07 | 17650234 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | ||
| 2021-10-12 | 17498796 | SUBSTITUTED ACETYLENIC PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220081440A1 | Dong Zou Wei-Sheng Huang R. Mathew Thomas Jan Antoinette C. Romero Jiwei Qi Yihan Wang Xiaotian Zhu William C. Shakespeare Rajeswari Sundaramoorthi Chester A. Metcalf III David C. Dalgarno Tomi K. Sawyer | United States United States United States United States United States United States United States United States United States United States United States United States | WILLIS, DOUGLAS M |
| 2021-08-12 | 17400820 | BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS | Ariad Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220064144A1 | Nicholas E. BENCIVENGA David C. DALGARNO Joseph M. GOZGIT Wei-Sheng HUANG Anna KOHLMANN Feng LI Jiwei QI William C. SHAKESPEARE Ranny M. THOMAS Yihan WANG Yun ZHANG Xiaotian ZHU | United States United States United States United States United States United States United States United States United States United States United States United States | PATEL, SAGAR S |
| 2021-03-05 | 17193502 | Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | Ariad Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20210186994A1 | Dauntel S. Verwijs Samir Desai Pradeep K. Sharma Leonard W. Rozamus Jeff Williamson Danica Cartwright Parag Ved | United States United States United States United States United States United States United States | |
| 2020-12-28 | 17135165 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | Ariad Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Wei-Sheng Huang Yongjin Gong Feng Li Nicholas E. Bencivenga David C. Dalgarno Anna Kohlmann William C. Shakespeare Ranny M. Thomas Xiaotian Zhu Angela V. West Willmen Youngsaye Yun Zhang Tianjun Zhou | United States United States United States United States United States United States United States United States United States United States United States United States United States | ||
| 2020-04-21 | 16853954 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | Ariad Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Wei-Sheng Huang Yongjin Gong Feng Li Nicholas E. Bencivenga David C. D a l g a r n o Anna Kohlmann William C. Shakespeare Ranny M. Thomas Xiaotian Zhu Angela V. West Willmen Youngsaye Yun Zhang Tianjun Zhou | United States United States United States United States United States United States United States United States United States United States United States United States United States | ||
| 2019-12-20 | 16722881 | Bicyclic Heteroaryl Compounds | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200231588A1 | Dong Zou Wei-Sheng Huang R. Mathew Thomas Jan Antoinette C. Romero Jiwei Qi Yihan Wang Xiaotian Zhu William C. Shakespeare Rajeswari Sundaramoorthi Chester A. Metcalf III David C. Dalgarno Tomi K. Sawyer | United States United States United States United States United States United States United States United States United States United States United States United States | WILLIS, DOUGLAS M |
| 2019-11-01 | 16672205 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200317705A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare Ranny M. Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | VAJDA, KRISTIN ANN |
| 2019-04-19 | 16389623 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200048288A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare Ranny M. Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2019-01-25 | 16257577 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | Ariad Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190218212A1 | Wei-Sheng Huang Yongjin Gong Feng Li Nicholas E. Bencivenga David C. Dalgarno Anna Kohlmann William C. Shakespeare Ranny M. Thomas Xiaotian Zhu Angela V. West Willmen Youngsaye Yun Zhang Tianjun Zhou | United States United States United States United States United States United States United States United States United States United States United States United States United States | AULAKH, CHARANJIT |
| 2018-08-06 | 16055362 | SUBSTITUTED ACETYLENIC PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190031656A1 | Dong Zou Wei-Sheng Huang R. Mathew Thomas Jan Antoinette C. Romero Jiwei Qi Yihan Wang Xiaotian Zhu William C. Shakespeare Rajeswari Sundaramoorthi Chester A. Metcalf III David C. Dalgarno Tomi K. Sawyer | United States United States United States United States United States United States United States United States United States United States United States United States | WILLIS, DOUGLAS M |
| 2018-03-07 | 15914899 | Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180256610A1 | Dauntel S. Verwijs Samir Desai Pradeep K. Sharma Leonard W. Rozamus Jeff Williamson Danica Cartwright Parag Ved | United States United States United States United States United States United States United States | BASQUILL, SEAN M |
| 2018-02-05 | 15573211 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | ARIAD Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20210323976A1 | Wei-Sheng Huang Tianjun Zhou Willmen W. Youngsaye William C. Shakespeare Alexey V. Ishchenko David C. Dalgarno | United States United States United States United States United States United States | |
| 2017-09-08 | 15699579 | MONOCYCLIC HETEROARYL COMPOUNDS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170369446A1 | William C. Shakespeare Wei-Sheng Huang David C. Dalgarno Xiaotian Zhu R. Mathew Thomas Yihan Wang Jiwei Qi Rajeswari Sundaramoorthi Dong Zou Chester A. Metcalf III Tomi K. Sawyer Jan Antoinette C. Romero | United States United States United States United States United States United States United States United States United States United States United States United States | OTTON, ALICIA L |
| 2017-04-17 | 15489593 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170218000A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare Ranny M. Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2016-11-10 | 15310349 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20170166598A1 | Wei-Sheng HUANG Feng LI David C. DALGARNO Yongjin GONG Alexey V. ISHCHENKO Anna KOHLMANN William C. SHAKESPEARE Angela V. WEST Yongjin XU Willmen YOUNGSAYE Yun ZHANG Tianjun ZHOU Xiaotian ZHU | United States United States United States United States United States United States United States United States United States United States United States United States United States | DESAI, RITA J |
| 2016-01-25 | 15005369 | Phosphorous Derivatives as Kinase Inhibitors | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160376297A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare Ranny M. Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2016-01-21 | 15003537 | SUBSTITUTED ACETYLENIC PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160368917A1 | Dong Zou Wei-Sheng Huang Ranny M. Thomas Jan Antoinette C. Romero Jiwei Qi Yihan Wang Xiaotian Zhu William C. Shakespeare Rajeswari Sundaramoorthi Chester A. Metcalf III David C. Dalgarno Tomi K. Sawyer | United States United States United States United States United States United States United States United States United States United States United States United States | WILLIS, DOUGLAS M |
| 2015-04-20 | 14690916 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20150225436A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare Ranny M. Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2014-11-04 | 14398893 | METHODS AND COMPOSITIONS FOR RAF KINASE MEDIATED DISEASES | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150166591A1 | Xiaotian Zhu Yihan Wang William C. Shakespeare Wei-Sheng Huang David C. Dalgarno | United States United States United States United States United States | BALASUBRAMANIAN, VENKATARAMAN |
| 2014-10-22 | 14396287 | Methods and Compositions for RAF Kinase Mediated Diseases | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150105377A1 | Joseph M. Gozgit Victor M. Rivera William C. Shakespeare Xiaotian Zhu David C. Dalgarno | United States United States United States United States United States | CORNET, JEAN P |
| 2014-08-26 | 14468512 | Pyrazinopyrazines and Derivatives as Kinase Inhibitors | ARIAD Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140364423A1 | Wei-Sheng Huang Ranny M. Thomas | United States United States | PIHONAK, SARAH |
| 2013-03-15 | 13843171 | Phosphorus Derivatives as Kinase Inhibitors | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130225527A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare R. Mathew Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2013-03-15 | 13843055 | Phosphorus Derivatives as Kinase Inhibitors | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130225528A1 | Yihan Wang Wei-Sheng Huang Shuangying Liu William C. Shakespeare R. Mathew Thomas Jiwei Qi Feng Li Xiaotian Zhu Anna Kohlmann David C. Dalgarno Jan Antoinette C. Romero Dong Zou | United States United States United States United States United States United States United States United States United States United States United States United States | CHENG, KAREN |
| 2013-03-14 | 13829175 | ORAL FORMULATIONS | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130202702A1 | Ronald S. Vladyka JR. David C. Dalgarno John D. IULlUCCI | United States United States United States | TRAN, SUSAN T |
| 2013-03-13 | 13802039 | Methods and Compositions for Treating Cancer | ARIAD PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130178622A1 | Wei-Sheng Huang Victor M. Rivera Timothy P. Clackson William C. Shakespeare Rachel M. Squillace Joseph M. Gozgit | United States United States United States United States United States United States | JEAN-LOUIS, SAMIRA JM |